IDYA vs SONY
Ideaya Biosciences Inc (IDYA) versus SONY (SONY) — a side-by-side from cached financials, not a winner call.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
SONY (SONY) common stock.
Latest reported IDYA revenue for 2026-06-30 was $15.4M. Net income was -$211.0M. IDYA currently screens at market cap $2.96B.
SONY does not have a complete income-statement cache yet.
IDYA currently screens at market cap $2.96B. SONY currently screens at market cap $0.
Not investment advice. Open the IDYA and SONY stock pages for the full models.
Not investment advice.